Nektar Therapeutics Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Insights

Nektar Therapeutics (NKTR)

65.25 -3.41 (-4.97%) USD | NASDAQ | Mar 30, 16:00

64.90 -0.35 (-0.54%) After-Hours: 20:00

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) for NKTR.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Benchmarks

Start Trial

Boston Scientific Corp.	Upgrade
Eli Lilly & Co.	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade
Rigel Pharmaceuticals, Inc.	Upgrade
Esperion Therapeutics, Inc.	Upgrade